"Since 1976, Associated Gastroenterology Medical Group has provided world-class gastroenterologist care in Orange County. We offer routine GI health services, including colonoscopy, colon cancer screening, and endoscopy. We treat the full spectrum of stomach, liver, and pancreas conditions. Some of the conditions we treat include severe heartburn, acid reflux, hemorrhoids, stomach & abdominal pain, liver disease, colitis, GERD, hepatitis, celiac disease, Crohn's disease, irritable bowel syndrome, gallstones, diverticular disease, and more. With offices in Anaheim and Tustin, we are easily accessible to patients from Irvine, Long Beach, Riverside County, Huntington Beach, Orange, Newport Beach, Torrance, Fullerton, Garden Grove and beyond."

During the past decade, AGMG Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AGMG Clinical Research" #1 sponsor was "Bausch Health Americas, Inc." with 4 trials, followed by "Pfizer" with 2 trials sponsored, "SciClone Pharmaceuticals" with 2 trials sponsored, "Chugai Pharma USA" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "AGMG Clinical Research" are "Ulcerative Colitis" (5 trials), "Chronic Hepatitis C" (2 trials), "Inflammatory Bowel Disease" (2 trials), "Adenoma" (1 trials) and "Bowel Preparation" (1 trials). Many other conditions were trialed in "AGMG Clinical Research" in a lesser frequency.

Most popular intervention types in "AGMG Clinical Research" are "Drug" (11 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "SCV-07" (2 trials), "Anrukinzumab" (1 trials), "Asacol 400 mg (mesalamine)" (1 trials), "Asacol 800 mg (mesalamine)" (1 trials) and "Balsalazide Disodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "AGMG Clinical Research" are 13 trials for "All" genders.

Currently, there are NaN active trials in "AGMG Clinical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in AGMG Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AGMG Clinical Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".